Use of genetics in the clinical evaluation of cardiomyopathy
- PMID: 19996403
- DOI: 10.1001/jama.2009.1787
Use of genetics in the clinical evaluation of cardiomyopathy
Abstract
Inherited forms of cardiomyopathy are frequently responsible for heart failure that is otherwise unexplained. Evaluation of familial cardiomyopathy should include not only the individual patient, but also the pattern of inheritance within the family and assessment for the presence of syndromic features. The last 10 years have seen remarkable advances in genetics. Improvements in technology have lowered costs, such that clinical use of genetic testing is rapidly expanding. Genetic counseling about the potential risks and benefits of such testing is an important part of the care of individuals and families with inherited heart disease. Among inherited types of cardiomyopathy, the likelihood of finding a responsible gene mutation varies. Both hypertrophic and right ventricular forms of cardiomyopathy have a relatively high likelihood of finding a responsible gene mutation when testing is properly applied. Because of prominent genetic heterogeneity in familial dilated cardiomyopathy, recognition of pathogenic mutations is more challenging. With or without genetic testing, screening of family members who are at risk for an inherited form of cardiomyopathy leads to earlier identification, earlier treatment, and improved outcomes.
Similar articles
-
Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.Circ Heart Fail. 2009 May;2(3):253-61. doi: 10.1161/CIRCHEARTFAILURE.108.817346. Circ Heart Fail. 2009. PMID: 19808347 Free PMC article. Review.
-
A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.J Cardiol. 2010 Sep;56(2):189-96. doi: 10.1016/j.jjcc.2010.04.003. Epub 2010 Jun 4. J Cardiol. 2010. PMID: 20605413
-
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.J Am Coll Cardiol. 2012 Aug 21;60(8):705-15. doi: 10.1016/j.jacc.2012.02.068. Epub 2012 Jul 11. J Am Coll Cardiol. 2012. PMID: 22796258 Review.
-
Genetic evaluation of familial cardiomyopathy.J Cardiovasc Transl Res. 2008 Jun;1(2):144-54. doi: 10.1007/s12265-008-9025-1. Epub 2008 Apr 22. J Cardiovasc Transl Res. 2008. PMID: 20559909 Review.
-
Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy.Acta Pol Pharm. 2010 Nov-Dec;67(6):669-72. Acta Pol Pharm. 2010. PMID: 21229884
Cited by
-
Dilated cardiomyopathy with conduction disease and arrhythmia.Circulation. 2010 Aug 3;122(5):527-34. doi: 10.1161/CIRCULATIONAHA.109.892240. Circulation. 2010. PMID: 20679582 Free PMC article. Review. No abstract available.
-
Update on heart failure management and future directions.Korean J Intern Med. 2019 Jan;34(1):11-43. doi: 10.3904/kjim.2018.428. Epub 2018 Dec 28. Korean J Intern Med. 2019. PMID: 30612416 Free PMC article. Review.
-
Use of genetics in the clinical evaluation and management of heart failure.Curr Treat Options Cardiovasc Med. 2010 Dec;12(6):566-77. doi: 10.1007/s11936-010-0092-7. Curr Treat Options Cardiovasc Med. 2010. PMID: 21063933
-
LV twisting and untwisting in HCM: ejection begets filling. Diastolic functional aspects of HCM.Am Heart J. 2011 Nov;162(5):798-810. doi: 10.1016/j.ahj.2011.08.019. Am Heart J. 2011. PMID: 22093194 Free PMC article.
-
Heart failure: advanced development in genetics and epigenetics.Biomed Res Int. 2015;2015:352734. doi: 10.1155/2015/352734. Epub 2015 Apr 9. Biomed Res Int. 2015. PMID: 25949994 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous